Sort
21,281 grants matching “influenza”
Oligomeric Structure of Membrane Peptides From Solid-State NMR
$687,411Mei Hong · Iowa State University · · FY2006 · BIO
Project 1: Human and Non-human Primate Influenza B-cell Repertoires
$687,400Michael Anthony Moody · Boston Children'S Hospital · P01 · FY2023 · AI
Negative regulation of innate immunity in influenza virus infection
$687,400Jian-Dong Li · Georgia State University · R01 · FY2025 · AI
Development of a Universal Influenza Vaccine Against Influenza A and B Viruses
$687,398Harvinder Singh Gill · Texas Tech University · R01 · FY2022 · AI
Project 2
$687,394Maria Virginia Pascual · St. Jude Children'S Research Hospital · U19 · FY2024 · AI
Epitope focusing by molecular grafting of subdominant epitopes to achieve a universal-influenza vaccine
$687,393Aaron Gregory Schmidt · Massachusetts General Hospital · R01 · FY2020 · AI
Targeting linear ubiquitination to attenuate inflammation and promote repair after IAV infection
$687,186Gr Scott Budinger · Northwestern University At Chicago · R01 · FY2020 · HL
Modeling Mechanisms of Adjuvanted Influenza Vaccine Induced IgG Repertoire Diversity and Heterosubtypic Immunity
$687,168Martin S Zand · University Of Rochester · R01 · FY2020 · AI
Neisserial porins and antigen presenting cells
$687,162Lee Mark Wetzler · Boston Medical Center · R01 · FY2017 · AI
Mechanistic Studies of Combination Adjuvants to Target B Cells in Vaccines
$687,160Luc Teyton · Scripps Research Institute, The · U01 · FY2024 · AI
DEVELOPING SUSTAINABLE INFLUENZA SURVEILLANCE NETWORKS AND RESPONSE TO AVIAN AND
$686,777Remigio Medina Olveda · Research Institute For Tropical Medicine · U51 · FY2009 · IP
Overcome immunodominance to support the development of universal influenza vaccines
$686,686Wei Luo · Indiana University Indianapolis · R01 · FY2025 · AI
Replication of influenza virus
$686,568Robert M Krug · University Of Texas At Austin · R01 · FY2011 · AI
Motivate, Vaccinate, Activateâ: An effectiveness-implementation trial to assess the impact of a multi-component community-based intervention to increase RSV vaccine uptake among Latino older adults
$686,134Carina Marquez · University Of California, San Francisco · R01 · FY2024 · MD
Motivate, Vaccinate, Activateâ: An effectiveness-implementation trial to assess the impact of a multi-component community-based intervention to increase RSV vaccine uptake among Latino older adults
$686,134Carina Marquez · University Of California, San Francisco · R01 · FY2025 · MD
HMGB1-mediated host response to chronic bacterial infection
$686,061Steven D Goodman · Research Inst Nationwide Children'S Hosp · R01 · FY2020 · AI
Staphylococcal superantigen and anthrax inhibitors
$685,723Patrick M Schlievert · University Of Chicago · U54 · FY2009 · AI
Using parenteral combination adjuvants to induce pan-mucosal cellular and humoral immunity
$685,533James B McLachlan · Tulane University Of Louisiana · R01 · FY2022 · AI
RNA:protein interactions that dictate the success of influenza virus infection
$685,427Andrew Mehle · University Of Wisconsin-Madison · R01 · FY2023 · AI
RNA:protein interactions that dictate the success of influenza virus infection
$685,427Andrew Mehle · University Of Wisconsin-Madison · R01 · FY2022 · AI
Resource Component
$685,235Matthew Jorgensen · Wake Forest University Health Sciences · P40 · FY2025 · OD
Epitope and mechanistic correlates of broadly protective human antibodies for pneumococcal infection
$685,212Jarrod Mousa · Florida State University · R01 · FY2024 · AI
Immunologic basis of cardiac disease after severe COVID-19
$685,031Chetan N Shenoy · University Of Minnesota · R01 · FY2023 · HL
Self-assembling nanoparticles for intranasal delivery of influenza fusion inhibitors
$684,836Matteo Porotto · Columbia University Health Sciences · R01 · FY2017 · AI
Epitope and mechanistic correlates of broadly protective human antibodies for pneumococcal infection
$684,721Jarrod Mousa · Florida State University · R01 · FY2025 · AI